{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:39:04Z","timestamp":1772357944426,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcf.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T01:16:16Z","timestamp":1708996576000},"page":"288-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-1039","authenticated-orcid":false,"given":"E.","family":"Ben-Meir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-8889","authenticated-orcid":false,"given":"L.","family":"Perrem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-6779","authenticated-orcid":false,"given":"M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-6592","authenticated-orcid":false,"given":"F.","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-9642","authenticated-orcid":false,"given":"H.","family":"Grasemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jcf.2024.02.009_bib0001","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.02.009_bib0002","volume":"2022","year":"2021"},{"key":"10.1016\/j.jcf.2024.02.009_bib0003","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ppul.22652","article-title":"Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis","volume":"48","author":"Wagener","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/thoraxjnl-2016-208450","article-title":"Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis","volume":"72","author":"Stanojevic","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.02.009_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld","year":"2001","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.02.009_bib0006","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1513\/AnnalsATS.201502-098AW","article-title":"Pulmonary Exacerbations in Children with Cystic Fibrosis","volume":"12","author":"Waters","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.jcf.2024.02.009_bib0007","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.202006-2433OC","article-title":"Lung clearance index to track acute respiratory events in school-age children with cystic fibrosis","volume":"203","author":"Perrem","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.02.009_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/thoraxjnl-2021-218347","article-title":"Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls","volume":"78","author":"Perrem","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.02.009_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2013.07.006","article-title":"Pulmonary exacerbations in CF patients with early lung disease","volume":"13","author":"Anstead","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2024.02.009_bib0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ppul.23056","article-title":"Pulmonary exacerbations, and parent-reported outcomes in children <6 years with cystic fibrosis","volume":"50","author":"Brumback","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0011","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ppul.22658","article-title":"Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms","volume":"48","author":"Regelmann","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ppul.23147","article-title":"Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site","volume":"50","author":"Schechter","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0013","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1165\/rcmb.2012-0072OC","article-title":"Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity","volume":"48","author":"Britto","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0014","doi-asserted-by":"crossref","first-page":"e64689","DOI":"10.1371\/journal.pone.0064689","article-title":"Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.02.009_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1165\/rcmb.2014-0297RT","article-title":"Bactericidal\/permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease","volume":"52","author":"Britto","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0016","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1038\/ncomms14118","article-title":"Identification of BPIFA1\/SPLUNC1 as an epithelium-derived smooth muscle relaxing factor","volume":"8","author":"Wu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2024.02.009_bib0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1165\/rcmb.2020-0452OC","article-title":"A SPLUNC1 peptidomimetic inhibits Orai1 and reduces inflammation in a murine allergic asthma model","volume":"66","author":"Wrennall","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.jcf.2024.02.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00668-2018","article-title":"SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration","volume":"52","author":"Webster","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2024.02.009_bib0019","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1465-9921-8-79","article-title":"Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis","volume":"8","author":"Bingle","year":"2007","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.jcf.2024.02.009_bib0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1165\/rcmb.2014-0182OC","article-title":"Polymorphisms associated with expression of BPIFA1\/BPIFB1 and lung disease severity in cystic fibrosis","volume":"53","author":"Saferali","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2024.02.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227067","article-title":"Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1","volume":"15","author":"Saferali","year":"2020","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jcf.2024.02.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00507-2020","article-title":"SPLUNC1: a novel marker of cystic fibrosis exacerbations","volume":"58","author":"Khanal","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jcf.2024.02.009_bib0023","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1183\/09031936.00211914","article-title":"LCI exacerbation - Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations","volume":"46","author":"Sonneveld","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.02.009_bib0027","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpeds.2022.01.040","article-title":"Lower airway nitrogen oxide levels in children with primary ciliary dyskinesia is linked to neutrophilic inflammation","volume":"244","author":"Grasemann","year":"2022","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2024.02.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02188-2018","article-title":"Hyperpolarised 129 Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis","volume":"53","author":"Rayment","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.02.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00244-2017","article-title":"Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations","volume":"50","author":"Grasemann","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2024.02.009_bib0026","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1183\/13993003.01390-2015","article-title":"Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia","volume":"47","author":"Ratjen","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jcf.2024.02.009_bib0028","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1183\/09031936.00195512","article-title":"Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry","volume":"42","author":"Quanjer","year":"2013","journal-title":"Eur Respir J"},{"issue":"8 Pt 1","key":"10.1016\/j.jcf.2024.02.009_bib0029","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1164\/ajrccm.164.8.2104075","article-title":"Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction","volume":"164","author":"Sagel","year":"2001","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:24:26Z","timestamp":1772353466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1569199324000249"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.009","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}